Journals / Ulusal Cerrahi Dergisi / 2009 / Cilt: 25 - Sayı: 3

The role of surgery in multidisciplinary approach to gastrointestinal stromal tumors: A case report

Gastrointestinal stromal tümörün multidisipliner tedavisinde cerrahinin yeri: Olgu sunumu

Pages
121–124
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study aims to discuss the role of surgery within such an approach, featuring a 62 year-old male patient having a gastrointestinal stromal tumor.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Although rare among tumors involving the gastrointestinal system, gastrointestinal stromal tumors are the most frequent mesenchymal tumors.
📊
Key Findings & Data:Recommended treatment regimens need to be updated as the multidisciplinary approach to both diagnosis and treatment of the tumor gains importance.
💡
Conclusion & Impact:This study aims to discuss the role of surgery within such an approach, featuring a 62 year-old male patient having a gastrointestinal stromal tumor.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Gastrointestinal stromal tümörler · Sindirim sistemi cerrahi işlemleri · Mide neoplazmları

Abstract

Although rare among tumors involving the gastrointestinal system, gastrointestinal stromal tumors are the most frequent mesenchymal tumors. Recommended treatment regimens need to be updated as the multidisciplinary approach to both diagnosis and treatment of the tumor gains importance. Surgery still holds place as the most important constituent of multidisciplinary in current algorythms and ongoing studies. Specific features of the surgical procedures and their combinations with other modalities are currently controversial issues. This study aims to discuss the role of surgery within such an approach, featuring a 62 year-old male patient having a gastrointestinal stromal tumor.

Özet

Gastrointestinal stromal tümör, gastrointestinal sistemin tüm tümörleri içinde nadir olmakla birlikte, mezenşimal tümörleri içinde en sık görülenidir. Hastalığın tanı ve tedavisindeki gelişmeler nedeniyle multidisipliner yaklaşımın önemi artmakta olup, önerilen tedavi yaklaşımları da güncellenmektedir. Mevcut algoritmalar ve sürmekte olan çalışmalarda, multidisipliner yaklaşım içinde cerrahinin önemi devam etmektedir. Uygulanacak cerrahinin özellikleri ve diğer tedavi yöntemleri ile ilişkisinde halen tartışmalı konular vardır. Bu çalışmada, 62 yaşında bir erkek gastrointestinal stromal tümör olgusunu, multidisipliner tedavide cerrahinin yerini tartışarak sunduk.

🔖

Cite This Article

KÖKSAL, N., UZUN, M. A., ALİUSTAOĞLU, M., KILIÇOĞLU, G. (2009). The role of surgery in multidisciplinary approach to gastrointestinal stromal tumors: A case report. Ulusal Cerrahi Dergisi, Cilt: 25 - Sayı: 3, 121–124. https://ajindex.com/articles/325518

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Gupta P, Tewari M, Shukla HS. Gastrointestinal stromal tumor. Surg Oncol 2008; 17: 129-138
  2. Kingham TP, DeMatteo RP. Multidisciplinary treatment of gastrointestinal stromal tumors. Surg Clin North Am 2009; 89: 217-233
  3. Nilsson B, Bümming P, Meis-Kindblom JM, Odén A, Dortok A, Gustavsson B, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era - a population-based study in western Sweden. Cancer 2005; 103: 821-829
  4. Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M. Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics 2003; 23: 283-304
  5. Goerres GW, Stupp R, Barghouth G, Hany TF, Pestalozzi B, Dizendorf E, et al. The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging 2005; 32: 153-162
  6. Everett M, Gutman H. Surgical management of gastrointestinal stromal tumors: analysis of outcome with respect to surgical margins and technique. J Surg Oncol 2008; 98: 588-593
  7. Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, et al. NCCN Task Force Report: Optimal management of patients with gastrointestinal stromal tumor (GIST) - update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 2007; 5 (Suppl 2): 1-29
  8. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000; 231: 51-58
  9. NCCN Clinical Practice Guidelines in Oncology. Soft Tissue Sarcoma, Gastrointestinal Stromal Tumors (GIST) v.1.2009
  10. NCCN Clinical Practice Guidelines in Oncology. Soft Tissue Sarcoma, Gastrointestinal Stromal Tumors (GIST) v.2.2007
  11. Verweij J, Casali PG, Zalcberg J, LeCesne A, Reichardt P, Blay JY, et al. Progression- free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet 2004; 364: 1127-1134. 12) van Oosterom AT, Judson I, Verweij J, Stroobants S, Donato di Paola E, Dimitrijevic S, et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 2001; 358: 1421-1423
  12. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347: 472-4